CS173591A3 - Testing process for the determination of an analytic agent amount in a sample employing internal calibration - Google Patents

Testing process for the determination of an analytic agent amount in a sample employing internal calibration Download PDF

Info

Publication number: CS173591A3
Authority: CS; Czechoslovakia
Prior art keywords: reagent; antibody; test; analyte; calibration
Prior art date: 1990-06-06

Application number

CS911735A

Other languages

Czech (cs)

English (en)

Inventor

Johan Selmer

Fritz Poulsen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-06

Filing date

1991-06-06

Publication date

1992-02-19

1991-06-06 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1992-02-19 Publication of CS173591A3 publication Critical patent/CS173591A3/cs

Links

238000012360 testing method Methods 0.000 title claims description 97
238000000034 method Methods 0.000 title claims description 49
239000003153 chemical reaction reagent Substances 0.000 claims description 115
239000012491 analyte Substances 0.000 claims description 57
230000027455 binding Effects 0.000 claims description 44
102000005962 receptors Human genes 0.000 claims description 29
108020003175 receptors Proteins 0.000 claims description 29
239000007787 solid Substances 0.000 claims description 28
238000003556 assay Methods 0.000 claims description 23
239000003795 chemical substances by application Substances 0.000 claims description 21
239000000126 substance Substances 0.000 claims description 19
239000000203 mixture Substances 0.000 claims description 18
239000012528 membrane Substances 0.000 claims description 17
102000004190 Enzymes Human genes 0.000 claims description 16
108090000790 Enzymes Proteins 0.000 claims description 16
229940088598 enzyme Drugs 0.000 claims description 16
239000012634 fragment Substances 0.000 claims description 14
230000003302 anti-idiotype Effects 0.000 claims description 12
239000000427 antigen Substances 0.000 claims description 11
108091007433 antigens Proteins 0.000 claims description 11
102000036639 antigens Human genes 0.000 claims description 11
108090001090 Lectins Proteins 0.000 claims description 10
102000004856 Lectins Human genes 0.000 claims description 10
239000002523 lectin Substances 0.000 claims description 10
239000000758 substrate Substances 0.000 claims description 8
210000004027 cell Anatomy 0.000 claims description 7
239000000306 component Substances 0.000 claims description 7
239000003102 growth factor Substances 0.000 claims description 7
239000000376 reactant Substances 0.000 claims description 7
102000003886 Glycoproteins Human genes 0.000 claims description 6
108090000288 Glycoproteins Proteins 0.000 claims description 6
229960004405 aprotinin Drugs 0.000 claims description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
-1 o ^ -foe-toprotein Proteins 0.000 claims description 6
239000002245 particle Substances 0.000 claims description 6
108700012359 toxins Proteins 0.000 claims description 6
108010039627 Aprotinin Proteins 0.000 claims description 5
108010001857 Cell Surface Receptors Proteins 0.000 claims description 5
102000000844 Cell Surface Receptors Human genes 0.000 claims description 5
102000004420 Creatine Kinase Human genes 0.000 claims description 5
108010042126 Creatine kinase Proteins 0.000 claims description 5
241001465754 Metazoa Species 0.000 claims description 5
108010046516 Wheat Germ Agglutinins Proteins 0.000 claims description 5
238000003149 assay kit Methods 0.000 claims description 5
150000001875 compounds Chemical class 0.000 claims description 5
239000002158 endotoxin Substances 0.000 claims description 5
150000004676 glycans Chemical class 0.000 claims description 5
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims description 5
229920001282 polysaccharide Polymers 0.000 claims description 5
239000005017 polysaccharide Substances 0.000 claims description 5
239000003053 toxin Substances 0.000 claims description 5
231100000765 toxin Toxicity 0.000 claims description 5
239000004382 Amylase Substances 0.000 claims description 4
102000013142 Amylases Human genes 0.000 claims description 4
108010065511 Amylases Proteins 0.000 claims description 4
108010074051 C-Reactive Protein Proteins 0.000 claims description 4
102100032752 C-reactive protein Human genes 0.000 claims description 4
101710172711 Structural protein Proteins 0.000 claims description 4
235000019418 amylase Nutrition 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 4
239000001913 cellulose Substances 0.000 claims description 4
108010008385 glycolipid receptor Proteins 0.000 claims description 4
102000004196 processed proteins & peptides Human genes 0.000 claims description 4
108090000765 processed proteins & peptides Proteins 0.000 claims description 4
102000004169 proteins and genes Human genes 0.000 claims description 4
108090000623 proteins and genes Proteins 0.000 claims description 4
210000001519 tissue Anatomy 0.000 claims description 4
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
244000105624 Arachis hypogaea Species 0.000 claims description 3
235000010777 Arachis hypogaea Nutrition 0.000 claims description 3
101800003838 Epidermal growth factor Proteins 0.000 claims description 3
102000004877 Insulin Human genes 0.000 claims description 3
108090001061 Insulin Proteins 0.000 claims description 3
108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
108091005804 Peptidases Proteins 0.000 claims description 3
102000013275 Somatomedins Human genes 0.000 claims description 3
108010008038 Synthetic Vaccines Proteins 0.000 claims description 3
230000001580 bacterial effect Effects 0.000 claims description 3
239000011230 binding agent Substances 0.000 claims description 3
229940116977 epidermal growth factor Drugs 0.000 claims description 3
229940088597 hormone Drugs 0.000 claims description 3
239000005556 hormone Substances 0.000 claims description 3
229940125396 insulin Drugs 0.000 claims description 3
239000003456 ion exchange resin Substances 0.000 claims description 3
229920003303 ion-exchange polymer Polymers 0.000 claims description 3
239000003446 ligand Substances 0.000 claims description 3
229920002521 macromolecule Polymers 0.000 claims description 3
244000052769 pathogen Species 0.000 claims description 3
239000004033 plastic Substances 0.000 claims description 3
229920003023 plastic Polymers 0.000 claims description 3
229920000642 polymer Polymers 0.000 claims description 3
229920001184 polypeptide Polymers 0.000 claims description 3
230000002285 radioactive effect Effects 0.000 claims description 3
210000002966 serum Anatomy 0.000 claims description 3
229920005573 silicon-containing polymer Polymers 0.000 claims description 3
230000004936 stimulating effect Effects 0.000 claims description 3
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
230000003612 virological effect Effects 0.000 claims description 3
229930195730 Aflatoxin Natural products 0.000 claims description 2
XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
235000017060 Arachis glabrata Nutrition 0.000 claims description 2
235000018262 Arachis monticola Nutrition 0.000 claims description 2
108010039209 Blood Coagulation Factors Proteins 0.000 claims description 2
102000015081 Blood Coagulation Factors Human genes 0.000 claims description 2
241000606161 Chlamydia Species 0.000 claims description 2
102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 2
108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 2
102100023804 Coagulation factor VII Human genes 0.000 claims description 2
102400001368 Epidermal growth factor Human genes 0.000 claims description 2
108010023321 Factor VII Proteins 0.000 claims description 2
108010054218 Factor VIII Proteins 0.000 claims description 2
102000001690 Factor VIII Human genes 0.000 claims description 2
108010088842 Fibrinolysin Proteins 0.000 claims description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 2
108010051696 Growth Hormone Proteins 0.000 claims description 2
108010052285 Membrane Proteins Proteins 0.000 claims description 2
102000018697 Membrane Proteins Human genes 0.000 claims description 2
102000035195 Peptidases Human genes 0.000 claims description 2
102000013566 Plasminogen Human genes 0.000 claims description 2
108010051456 Plasminogen Proteins 0.000 claims description 2
108010094028 Prothrombin Proteins 0.000 claims description 2
102100027378 Prothrombin Human genes 0.000 claims description 2
108090000190 Thrombin Proteins 0.000 claims description 2
239000005409 aflatoxin Substances 0.000 claims description 2
210000004381 amniotic fluid Anatomy 0.000 claims description 2
238000012801 analytical assay Methods 0.000 claims description 2
210000004369 blood Anatomy 0.000 claims description 2
239000008280 blood Substances 0.000 claims description 2
239000003114 blood coagulation factor Substances 0.000 claims description 2
239000012503 blood component Substances 0.000 claims description 2
210000001124 body fluid Anatomy 0.000 claims description 2
239000010839 body fluid Substances 0.000 claims description 2
210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
229940015047 chorionic gonadotropin Drugs 0.000 claims description 2
206010013023 diphtheria Diseases 0.000 claims description 2
229940012413 factor vii Drugs 0.000 claims description 2
229960000301 factor viii Drugs 0.000 claims description 2
210000003608 fece Anatomy 0.000 claims description 2
229940126864 fibroblast growth factor Drugs 0.000 claims description 2
230000003325 follicular Effects 0.000 claims description 2
210000004051 gastric juice Anatomy 0.000 claims description 2
239000000122 growth hormone Substances 0.000 claims description 2
239000000463 material Substances 0.000 claims description 2
230000000813 microbial effect Effects 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
235000020232 peanut Nutrition 0.000 claims description 2
229940012957 plasmin Drugs 0.000 claims description 2
229940039716 prothrombin Drugs 0.000 claims description 2
239000003270 steroid hormone Substances 0.000 claims description 2
210000001138 tear Anatomy 0.000 claims description 2
229960004072 thrombin Drugs 0.000 claims description 2
210000002700 urine Anatomy 0.000 claims description 2
235000010469 Glycine max Nutrition 0.000 claims 4
244000068988 Glycine max Species 0.000 claims 4
108010062580 Concanavalin A Proteins 0.000 claims 3
108010046016 Peanut Agglutinin Proteins 0.000 claims 2
229910010293 ceramic material Inorganic materials 0.000 claims 2
239000005373 porous glass Substances 0.000 claims 2
239000011148 porous material Substances 0.000 claims 2
235000003276 Apios tuberosa Nutrition 0.000 claims 1
235000010744 Arachis villosulicarpa Nutrition 0.000 claims 1
108030001720 Bontoxilysin Proteins 0.000 claims 1
206010008631 Cholera Diseases 0.000 claims 1
108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
108010071289 Factor XIII Proteins 0.000 claims 1
102000018997 Growth Hormone Human genes 0.000 claims 1
108010079723 Shiga Toxin Proteins 0.000 claims 1
102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
229940053031 botulinum toxin Drugs 0.000 claims 1
210000004246 corpus luteum Anatomy 0.000 claims 1
229940012444 factor xiii Drugs 0.000 claims 1
235000013305 food Nutrition 0.000 claims 1
210000002751 lymph Anatomy 0.000 claims 1
210000003097 mucus Anatomy 0.000 claims 1
230000009871 nonspecific binding Effects 0.000 claims 1
210000002381 plasma Anatomy 0.000 claims 1
230000001698 pyrogenic effect Effects 0.000 claims 1
230000011664 signaling Effects 0.000 claims 1
239000004094 surface-active agent Substances 0.000 claims 1
229960000187 tissue plasminogen activator Drugs 0.000 claims 1
230000009466 transformation Effects 0.000 claims 1
108010062374 Myoglobin Proteins 0.000 description 9
102100030856 Myoglobin Human genes 0.000 description 9
238000011088 calibration curve Methods 0.000 description 8
108010001336 Horseradish Peroxidase Proteins 0.000 description 5
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
239000004816 latex Substances 0.000 description 3
229920000126 latex Polymers 0.000 description 3
239000010410 layer Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
241000283690 Bos taurus Species 0.000 description 2
108090000371 Esterases Proteins 0.000 description 2
101000635854 Homo sapiens Myoglobin Proteins 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
239000000975 dye Substances 0.000 description 2
239000012530 fluid Substances 0.000 description 2
239000003547 immunosorbent Substances 0.000 description 2
238000011534 incubation Methods 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
238000012207 quantitative assay Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000010998 test method Methods 0.000 description 2
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
JTNGEYANGCBZLK-UHFFFAOYSA-N 1h-indol-3-yl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CNC2=C1 JTNGEYANGCBZLK-UHFFFAOYSA-N 0.000 description 1
WONRDHPFOHAWOG-UHFFFAOYSA-N 2-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Cl)C=CC2=C1 WONRDHPFOHAWOG-UHFFFAOYSA-N 0.000 description 1
ZHMMPVANGNPCBW-UHFFFAOYSA-N 4-Hydroxyhydratropate Chemical compound OC(=O)C(C)C1=CC=C(O)C=C1 ZHMMPVANGNPCBW-UHFFFAOYSA-N 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
241000271566 Aves Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
241000193155 Clostridium botulinum Species 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
101710088235 Envelope glycoprotein C homolog Proteins 0.000 description 1
102000009024 Epidermal Growth Factor Human genes 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
102100022624 Glucoamylase Human genes 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
241001611408 Nebo Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000052651 Pancreatic hormone Human genes 0.000 description 1
108700020479 Pancreatic hormone Proteins 0.000 description 1
108700020962 Peroxidase Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
108010064851 Plant Proteins Proteins 0.000 description 1
108010001014 Plasminogen Activators Proteins 0.000 description 1
102000001938 Plasminogen Activators Human genes 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229940019700 blood coagulation factors Drugs 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000003086 colorant Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000012467 final product Substances 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
108010030727 lens intermediate filament proteins Proteins 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
238000001471 micro-filtration Methods 0.000 description 1
239000012982 microporous membrane Substances 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
235000021118 plant-derived protein Nutrition 0.000 description 1
229940127126 plasminogen activator Drugs 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
239000012629 purifying agent Substances 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
239000012070 reactive reagent Substances 0.000 description 1
239000002356 single layer Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Automatic Analysis And Handling Materials Therefor (AREA)

CS911735A 1990-06-06 1991-06-06 Testing process for the determination of an analytic agent amount in a sample employing internal calibration CS173591A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK138090A DK138090D0 (da)	1990-06-06	1990-06-06	Diagnostisk analysemetode

Publications (1)

Publication Number	Publication Date
CS173591A3 true CS173591A3 (en)	1992-02-19

Family

ID=8104233

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS911735A CS173591A3 (en)	1990-06-06	1991-06-06	Testing process for the determination of an analytic agent amount in a sample employing internal calibration

Country Status (8)

Country	Link
US (1)	US5387503A (da)
EP (1)	EP0532627A1 (da)
JP (1)	JPH05508013A (da)
AU (1)	AU7967891A (da)
CS (1)	CS173591A3 (da)
DK (1)	DK138090D0 (da)
WO (1)	WO1991019196A1 (da)
ZA (1)	ZA914068B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ299602B6 (cs) *	1997-05-02	2008-09-17		Zpusob imunitního stanovení analytu v kapalném vzorku a systém pro kontinuální provádení identických nebo obdobných imunostanovení v kapalných vzorcích biologické tekutiny

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5447838A (en) *	1992-08-05	1995-09-05	Hybritech Incorporated	Protein-dye conjugate for confirmation of correct dilution of calibrators
DE4439756C2 (de) *	1994-11-09	2002-07-18	Dade Behring Marburg Gmbh	Kalibrator zur Verwendung in Testverfahren zum Nachweis eines defekten Gerinnungsfaktors V
US5903005A (en) *	1995-09-29	1999-05-11	Hughes Electronics	Aspherical elements for infrared imaging system
US6057166A (en) *	1995-12-22	2000-05-02	Universal Healthwatch, Inc.	Fecal test method
JP2000502452A (ja) *	1995-12-22	2000-02-29	ユニバーサルヘルスウォッチ，インコーポレーテッド	糞便の試験方法及び用具
US6015662A (en) *	1996-01-23	2000-01-18	Abbott Laboratories	Reagents for use as calibrators and controls
US5874216A (en) *	1996-02-23	1999-02-23	Ensys Environmental Products, Inc.	Indirect label assay device for detecting small molecules and method of use thereof
US6194222B1 (en) *	1998-01-05	2001-02-27	Biosite Diagnostics, Inc.	Methods for monitoring the status of assays and immunoassays
US7713703B1 (en)	2000-11-13	2010-05-11	Biosite, Inc.	Methods for monitoring the status of assays and immunoassays
DE19838429C2 (de) *	1998-08-24	2001-07-26	Fraunhofer Ges Forschung	Anordnung zum schnellen Nachweis von mikrobiologischen oder biochemischen Stoffen
DE19855819C2 (de) *	1998-12-03	2001-02-15	Roche Diagnostics Gmbh	Stabilisierung von Cytokeratin enthaltenden Kalibratoren
JP4542242B2 (ja) *	2000-07-24	2010-09-08	シスメックス株式会社	標準試料及び調製法
US8367013B2 (en) *	2001-12-24	2013-02-05	Kimberly-Clark Worldwide, Inc.	Reading device, method, and system for conducting lateral flow assays
US6837171B1 (en)	2002-04-29	2005-01-04	Palmer/Snyder Furniture Company	Lightweight table with unitized table top
US20030119203A1 (en) *	2001-12-24	2003-06-26	Kimberly-Clark Worldwide, Inc.	Lateral flow assay devices and methods for conducting assays
US7432105B2 (en) *	2002-08-27	2008-10-07	Kimberly-Clark Worldwide, Inc.	Self-calibration system for a magnetic binding assay
US7314763B2 (en) *	2002-08-27	2008-01-01	Kimberly-Clark Worldwide, Inc.	Fluidics-based assay devices
US7285424B2 (en) *	2002-08-27	2007-10-23	Kimberly-Clark Worldwide, Inc.	Membrane-based assay devices
US7781172B2 (en) *	2003-11-21	2010-08-24	Kimberly-Clark Worldwide, Inc.	Method for extending the dynamic detection range of assay devices
US20040106190A1 (en) *	2002-12-03	2004-06-03	Kimberly-Clark Worldwide, Inc.	Flow-through assay devices
US20040121334A1 (en) *	2002-12-19	2004-06-24	Kimberly-Clark Worldwide, Inc.	Self-calibrated flow-through assay devices
US7247500B2 (en)	2002-12-19	2007-07-24	Kimberly-Clark Worldwide, Inc.	Reduction of the hook effect in membrane-based assay devices
US7851209B2 (en) *	2003-04-03	2010-12-14	Kimberly-Clark Worldwide, Inc.	Reduction of the hook effect in assay devices
US20040197819A1 (en) *	2003-04-03	2004-10-07	Kimberly-Clark Worldwide, Inc.	Assay devices that utilize hollow particles
US7713748B2 (en) *	2003-11-21	2010-05-11	Kimberly-Clark Worldwide, Inc.	Method of reducing the sensitivity of assay devices
US20050112703A1 (en) *	2003-11-21	2005-05-26	Kimberly-Clark Worldwide, Inc.	Membrane-based lateral flow assay devices that utilize phosphorescent detection
US7943395B2 (en) *	2003-11-21	2011-05-17	Kimberly-Clark Worldwide, Inc.	Extension of the dynamic detection range of assay devices
US7943089B2 (en) *	2003-12-19	2011-05-17	Kimberly-Clark Worldwide, Inc.	Laminated assay devices
US20050136550A1 (en) *	2003-12-19	2005-06-23	Kimberly-Clark Worldwide, Inc.	Flow control of electrochemical-based assay devices
US7521226B2 (en) *	2004-06-30	2009-04-21	Kimberly-Clark Worldwide, Inc.	One-step enzymatic and amine detection technique
US20060199221A1 (en) *	2005-03-07	2006-09-07	Samad Talebpour	Correction for temperature dependence assays
US7939342B2 (en) *	2005-03-30	2011-05-10	Kimberly-Clark Worldwide, Inc.	Diagnostic test kits employing an internal calibration system
US7439079B2 (en) *	2005-04-29	2008-10-21	Kimberly-Clark Worldwide, Inc.	Assay devices having detection capabilities within the hook effect region
US7829347B2 (en) *	2005-08-31	2010-11-09	Kimberly-Clark Worldwide, Inc.	Diagnostic test kits with improved detection accuracy
US8185319B2 (en) *	2006-01-19	2012-05-22	Novx Systems Canada Inc.	Method of compensation of dose-response curve of an assay for sensitivity to perturbing variables
US8185318B2 (en) *	2006-01-19	2012-05-22	Novx Systems Canada Inc.	Method of compensation of dose-response curve of an assay for sensitivity to perturbing variables
WO2008109977A1 (en) *	2007-03-12	2008-09-18	Novx Systems Inc.	Method of compensation of dose-response curve of an assay for sensitivity to perturbing variables
EP2342351B1 (en) *	2008-10-24	2016-01-13	Novo Nordisk Health Care AG	Method of quality control testing a factor xiii containing sample
US8643837B2 (en) *	2009-01-14	2014-02-04	Alverix, Inc.	Methods and materials for calibration of a reader
EP2459730B1 (en)	2009-07-27	2016-12-07	Suresensors LTD	Improvements relating to sensor devices
US9157910B2 (en)	2013-03-15	2015-10-13	Abbott Laboratories	Assay with increased dynamic range
US9005901B2 (en) *	2013-03-15	2015-04-14	Abbott Laboratories	Assay with internal calibration
JP2023542867A (ja)	2020-09-11	2023-10-12	グリンプスバイオ，インコーポレイテッド	疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出
EP4490309A4 (en) *	2022-03-09	2026-05-06	Sunbird Bio Inc	Method of protease detection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4849338A (en) *	1982-07-16	1989-07-18	Syntex (U.S.A.) Inc.	Simultaneous calibration heterogeneous immunoassay
US4533629A (en) *	1981-04-17	1985-08-06	Syva Company	Simultaneous calibration heterogeneous immunoassay
US4540659A (en) *	1981-04-17	1985-09-10	Syva Company	Simultaneous calibration heterogeneous immunoassay
US4791056A (en) *	1984-03-27	1988-12-13	Syntex (U.S.A.) Inc.	Calibration device for heterogeneous immunoassay
FI76119C (fi) *	1986-02-27	1988-09-09	Orion Yhtymae Oy	Kvantitativ bestaemning av nukleinsyramolekyler och reagensfoerpackning som anvaends vid foerfarandet.
JPS62231168A (ja) *	1986-03-21	1987-10-09	ハイブリテツク・インコ−ポレイテツド	アナライト−レセプタ−分析用内部標準を設けるための改良法
AU7385687A (en) *	1986-06-09	1987-12-10	Ortho Diagnostic Systems Inc.	Immunoglobulin immunoassay with internalized control assays
US4940658A (en) *	1986-11-20	1990-07-10	University Patents, Inc.	Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency
GB8812213D0 (en) *	1988-05-24	1988-06-29	Ares Serono Res & Dev Ltd	Method of assay

1990
- 1990-06-06 DK DK138090A patent/DK138090D0/da unknown
1991
- 1991-05-29 ZA ZA914068A patent/ZA914068B/xx unknown
- 1991-06-06 WO PCT/DK1991/000151 patent/WO1991019196A1/en not_active Ceased
- 1991-06-06 CS CS911735A patent/CS173591A3/cs unknown
- 1991-06-06 US US07/938,039 patent/US5387503A/en not_active Expired - Fee Related
- 1991-06-06 JP JP91510326A patent/JPH05508013A/ja active Pending
- 1991-06-06 EP EP91911152A patent/EP0532627A1/en not_active Ceased
- 1991-06-06 AU AU79678/91A patent/AU7967891A/en not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ299602B6 (cs) *	1997-05-02	2008-09-17		Zpusob imunitního stanovení analytu v kapalném vzorku a systém pro kontinuální provádení identických nebo obdobných imunostanovení v kapalných vzorcích biologické tekutiny

Also Published As

Publication number	Publication date
ZA914068B (en)	1992-03-25
AU7967891A (en)	1991-12-31
EP0532627A1 (en)	1993-03-24
JPH05508013A (ja)	1993-11-11
WO1991019196A1 (en)	1991-12-12
DK138090D0 (da)	1990-06-06
US5387503A (en)	1995-02-07

Publication	Publication Date	Title
CS173591A3 (en)	1992-02-19	Testing process for the determination of an analytic agent amount in a sample employing internal calibration
EP0171150B1 (en)	1992-03-25	Method and apparatus for assaying with optional reagent quality control
US5028535A (en)	1991-07-02	Threshold ligand-receptor assay
US6998246B2 (en)	2006-02-14	Method for immobilizing conjugates in diagnostic tests
US5770457A (en)	1998-06-23	Rapid oneside single targeting (ROST) immunoassay method
US20040241876A1 (en)	2004-12-02	Flow through assay device, diagnostic kit comprising said assay device and use of said assay device in the detection of an analyte present in a sample
US5738986A (en)	1998-04-14	Analytical reagent particle with covalently-bound enzyme
JPH0731199B2 (ja)	1995-04-10	低ｐＩ蛋白質または炭水化物を含んでなる特異的バインディング組成物ならびに診断試験キットおよび使用方法
JP4426103B2 (ja)	2010-03-03	生物流体中のβ−ラクタム環を含む抗生物質を測定するための方法
EP1344059B1 (en)	2007-10-10	Flow through assay device, diagnostic kit comprising said device and use in the detection of an analyte in a sample
IE66474B1 (en)	1995-12-27	Test method and reagent kit therefor
EP0902287B1 (en)	2003-11-19	Method and test strip for reducing urea effect of immunochromatographic assays using urine samples
AU628298B2 (en)	1992-09-17	Method for measuring human insulin
JPS63501819A (ja)	1988-07-21	イムノアッセイ法およびキット
US20080227220A1 (en)	2008-09-18	Lateral Flow Binding Assay
JPH06505803A (ja)	1994-06-30	マルチテスト免疫化学的試薬及びその使用方法
SU1691754A1 (ru)	1991-11-15	Способ проведени точечного иммуноферментного анализа
CA1336163C (en)	1995-07-04	Enzyme quantitation wicking assay
JPH05209879A (ja)	1993-08-20	ヘモグロビンの免疫学的検出方法
Monroe	1989	Enzyme Channelling Immunoassay (ECIA): A Unique and Rapid Quantitative Technique
MONROE	2016	6. Enzyme Channelling Immunoassay (ECIA): A Unique and Rapid Quantitative
JPH10282103A (ja)	1998-10-23	免疫分析要素および免疫分析方法
Mock	1988	The development of an enzyme-linked immunosorbent assay for bovine lactoferrin: a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Biochemistry at Massey University
JPWO1999060401A1 (ja)	2002-11-12	免疫測定試薬および免疫測定法
EP0379347A2 (en)	1990-07-25	Enzyme-labeled receptor composition, diagnostic kit and use in method to determine a ligand

CS173591A3 - Testing process for the determination of an analytic agent amount in a sample employing internal calibration - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=8104233

Family Applications (1)

Country Status (8)

Cited By (1)

Families Citing this family (44)

Family Cites Families (9)

Cited By (1)

Also Published As

Similar Documents